Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-25-000343
Filing Date
2025-11-10
Accepted
2025-11-10 17:01:17
Documents
59
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025 bivi-20250930_10q.htm   iXBRL 10-Q 556283
2 EXHIBIT 31.1 bivi-20250930_10qex31z1.htm EX-31.1 12097
3 EXHIBIT 31.2 bivi-20250930_10qex31z2.htm EX-31.2 12263
4 EXHIBIT 32.1 bivi-20250930_10qex32z1.htm EX-32.1 5291
5 EXHIBIT 32.2 bivi-20250930_10qex32z2.htm EX-32.2 5140
  Complete submission text file 0001520138-25-000343.txt   3528988

Data Files

Seq Description Document Type Size
6 XBRL CALCULATION FILE bivi-20250930_cal.xml EX-101.CAL 44655
7 XBRL DEFINITION FILE bivi-20250930_def.xml EX-101.DEF 125236
8 XBRL LABEL FILE bivi-20250930_lab.xml EX-101.LAB 246666
9 XBRL PRESENTATION FILE bivi-20250930_pre.xml EX-101.PRE 201323
10 XBRL SCHEMA FILE bivi-20250930.xsd EX-101.SCH 33681
61 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20250930_10q_htm.xml XML 441138
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 251467220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)